Rozlytrek – Roche’s First FDA Approved Tumour-Agnostic Medicine
Posted by
www.biotecnika.org
Rozlytrek – Roche's first FDA approved tumour-agnostic medicine Roche,
an international pioneer in pharmaceuticals, today announced that the
US Food and Drug Administration (FDA) has approved Roche's
tumour-agnostic medicine named Rozlytrek for the treatment of adults
with ROS1-positive and metastatic non-small cell lung cancer. The FDA
has also granted accelerated approval to Roche's tumor-agnostic
medicine […]
The post Rozlytrek – Roche's First FDA Approved Tumour-Agnostic
Medicine appeared first on Rasayanika .
https://www.rasayanika.com/2019/08/20/roche-tumour-agnostic-medicine-rozlytrek-approved-by-fda/
News
Subscribe to:
Post Comments (Atom)
Post a Comment